SCHEMBL6026073

SCHEMBL6026073

Cc1nc(Cl)c2cccc(Br)c2n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.49
ENPP3 O14638 1/20 0.45
ENPP1 P22413 1/20 0.45
MAPT P10636 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
GAA P10253 1/20 0.38
CYP2A6 P11509 1/20 0.38
ADORA1 P30542 1/20 0.37
HRH4 Q9H3N8 1/20 0.37
AR P10275 1/20 0.36
TDP1 Q9NUW8 1/20 0.35
KMT2A Q03164 4/20 0.35
MEN1 O00255 3/20 0.35
POLB P06746 1/20 0.35
LMNA P02545 1/20 0.35
PRNP P04156 1/20 0.35
BACE1 P56817 1/20 0.35
GRM2 Q14416 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL558543 0.81 ENPP3 (0.47) ALDH1A1ENPP3ENPP1MAPTSMN1; SMN2
SCHEMBL14842961 0.78 SSTR4 (0.39) ALDH1A1MAPTSMN1; SMN2CYP2A6ADORA1
SCHEMBL29209692 0.78 HRH4 (0.47) ALDH1A1ENPP3ENPP1MAPTSMN1; SMN2
SCHEMBL30881846 0.78 HRH4 (0.47) ALDH1A1ENPP3ENPP1MAPTSMN1; SMN2
SCHEMBL6025148 0.78 MAPT (0.44) ALDH1A1ENPP3ENPP1MAPTSMN1; SMN2
SCHEMBL3242174 0.78 PARP1 (0.47) ALDH1A1MAPTSMN1; SMN2GAACYP2A6
SCHEMBL2712257 0.76 ALDH1A1 (0.55) ALDH1A1ENPP3ENPP1MAPTSMN1; SMN2
SCHEMBL23497072 0.75 ALDH1A1 (0.44) ALDH1A1ENPP3ENPP1BACE1CYP1A2
SCHEMBL29829159 0.75 ALDH1A1 (0.44) ALDH1A1ENPP3ENPP1BACE1CYP1A2
SCHEMBL7748193 0.75 KDM4E (0.54) ALDH1A1MAPTSMN1; SMN2GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118026880-A Aryl amide compound, pharmaceutical composition containing same and application thereof 华东师范大学 2024-05-14 CN disclosed
EP-0966442-B1 QUINOLINE AND QUINAZOLINE DERIVATIVES HAVING CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONIST ACTIVITY DUPHAR INT RES (NL) 2006-12-20 EP disclosed
US-6350750-B1 TREATMENT OF STRESS-RELATED DISORDERS; ARYLATION WITH BORONIC ACID DERIVATIVE, AMINATION DUPHAR INTERNATIONAL RESEARCH B.V. (NL) 2002-02-26 US disclosed
EP-0966442-A1 QUINOLINE AND QUINAZOLINE DERIVATIVES HAVING CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONIST ACTIVITY DUPHAR INTERNATIONAL RESEARCH B.V (NL) 1999-12-29 EP disclosed
WO-1999012908-A1 QUINOLINE AND QUINAZOLINE DERIVATIVES HAVING CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONIST ACTIVITY DUPHAR INTERNATIONAL RESEARCH B.V. (NL) 1999-03-18 WO disclosed